Spero Therapeutics, Inc. Quarterly Operating Margin in % from Q4 2017 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Spero Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2017 to Q2 2024.
  • Spero Therapeutics, Inc. Operating Margin for the quarter ending June 30, 2024 was 13.1 %.
  • Spero Therapeutics, Inc. annual Operating Margin for 2023 was 20.7 %.
  • Spero Therapeutics, Inc. annual Operating Margin for 2022 was -78.9 %, a 83.6% increase from 2021.
  • Spero Therapeutics, Inc. annual Operating Margin for 2021 was -482 %, a 43.2% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 13.1 +37.2 Apr 1, 2024 Jun 30, 2024
Q1 2024 19.6 +68.6 Jan 1, 2024 Mar 31, 2024
Q4 2023 20.7 +99.6 Oct 1, 2023 Dec 31, 2023
Q3 2023 -4.02 +1.08K +99.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 -24 +1.05K +97.8% Apr 1, 2023 Jun 30, 2023
Q1 2023 -49 +709 +93.5% Jan 1, 2023 Mar 31, 2023
Q4 2022 -78.9 +403 +83.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -1.09K -630 -138% Jul 1, 2022 Sep 30, 2022
Q2 2022 -1.08K -664 -161% Apr 1, 2022 Jun 30, 2022
Q1 2022 -758 -251 -49.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 -482 +366 +43.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 -455 +325 +41.7% Jul 1, 2021 Sep 30, 2021
Q2 2021 -413 +315 +43.3% Apr 1, 2021 Jun 30, 2021
Q1 2021 -507 +155 +23.4% Jan 1, 2021 Mar 31, 2021
Q4 2020 -848 -500 -143% Oct 1, 2020 Dec 31, 2020
Q3 2020 -780 -481 -161% Jul 1, 2020 Sep 30, 2020
Q2 2020 -728 -389 -115% Apr 1, 2020 Jun 30, 2020
Q1 2020 -662 -304 -85.1% Jan 1, 2020 Mar 31, 2020
Q4 2019 -348 +731 +67.7% Oct 1, 2019 Dec 31, 2019
Q3 2019 -299 +1.1K +78.7% Jul 1, 2019 Sep 30, 2019
Q2 2019 -338 +1.06K +75.8% Apr 1, 2019 Jun 30, 2019
Q1 2019 -358 +1.14K +76.2% Jan 1, 2019 Mar 31, 2019
Q4 2018 -1.08K +1.03K +48.8% Oct 1, 2018 Dec 31, 2018
Q3 2018 -1.4K Jul 1, 2018 Sep 30, 2018
Q2 2018 -1.4K Apr 1, 2018 Jun 30, 2018
Q1 2018 -1.5K Jan 1, 2018 Mar 31, 2018
Q4 2017 -2.11K Oct 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.